More recent evidence suggested that TRAF2 stimulates fibroblast activation and ECM deposition by modulating pro-inflammatory and pro-fibrotic signaling pathways in pulmonary fibrosis (17). This evidence concerns the gene TRAF2 and pulmonary fibrosis.